CIK 0001020214 · Accelerated filer
CERUS CORP
Sign in to watch- Ticker
- CERS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 680262011
- Phone
- 9252886000
- Business address
- 1220 CONCORD AVENUE, SUITE 600, CONCORD, CA, 94520
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $89,529
- in 1 filing, $90K under 10b5-1 plans
Net −$89,529. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-03-12 | CORASH LAURENCE M Chief Scientific Officer | Option exercise · Restricted Stock Unit | −45,000 | 90,000 | ||
| 2020-03-12 | Benjamin Richard J Chief Medical Officer | Option exercise · Restricted Stock Unit | −7,500 | 0 | ||
| 2020-03-12 | Benjamin Richard J Chief Medical Officer | Option exercise · Restricted Stock Unit | −15,833 | 15,833 | ||
| 2020-03-12 | Benjamin Richard J Chief Medical Officer | Option exercise · Restricted Stock Unit | −45,000 | 90,000 | ||
| 2020-03-04 | NACHTSHEIM JAMI K Director | Option exercise | +5,128 | 7,538 | ||
| 2020-03-04 | NACHTSHEIM JAMI K Director | Option exercise · Restricted Stock Unit | −5,128 | 10,254 | ||
| 2020-03-02 | Moore Carol SVP Reg. & Quality | Grant or award · Option (Right to Buy) | +138,000 | 138,000 | ||
| 2020-03-02 | Moore Carol SVP Reg. & Quality | Grant or award · Restricted Stock Unit | +69,000 | 69,000 | ||
| 2020-03-02 | Menard Chrystal Chief Legal Officer | Grant or award · Option (Right to Buy) | +138,000 | 138,000 | ||
| 2020-03-02 | Menard Chrystal Chief Legal Officer | Grant or award · Restricted Stock Unit | +69,000 | 69,000 | ||
| 2020-03-02 | Jayaraman Vivek K Chief Operating Officer | Grant or award · Option (Right to Buy) | +260,000 | 260,000 | ||
| 2020-03-02 | Jayaraman Vivek K Chief Operating Officer | Grant or award · Restricted Stock Unit | +130,000 | 130,000 | ||
| 2020-03-02 | Green Kevin Dennis Chief Financial Officer | Grant or award · Option (Right to Buy) | +138,000 | 138,000 | ||
| 2020-03-02 | Green Kevin Dennis Chief Financial Officer | Grant or award · Restricted Stock Unit | +69,000 | 69,000 | ||
| 2020-03-02 | Greenman William Mariner President and CEO | Grant or award · Option (Right to Buy) | +632,500 | 632,500 | ||
| 2020-03-02 | Greenman William Mariner President and CEO | Grant or award · Restricted Stock Unit | +316,250 | 316,250 | ||
| 2020-03-02 | CORASH LAURENCE M Chief Scientific Officer | Grant or award · Option (Right to Buy) | +138,000 | 138,000 | ||
| 2020-03-02 | CORASH LAURENCE M Chief Scientific Officer | Grant or award · Restricted Stock Unit | +69,000 | 69,000 | ||
| 2020-03-02 | Benjamin Richard J Chief Medical Officer | Grant or award · Option (Right to Buy) | +138,000 | 138,000 | ||
| 2020-03-02 | Benjamin Richard J Chief Medical Officer | Grant or award · Restricted Stock Unit | +69,000 | 69,000 |
Page 34 of 44 · 870 trades